Electra Therapeutics, a clinical-stage biotech focused on immunology and cancer therapies, raised $183M in a Series C round co-led by Nextech and EQT Life Sciences. New investors Sanofi, HBM Healthcare Investments and Mubadala Capital participated alongside existing backers.
Comments
Want to join the conversation?
Loading comments...